These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1534511

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.
    Denmeade SR, Lin XS, Isaacs JT.
    Prostate; 1996 Apr; 28(4):251-65. PubMed ID: 8602401
    [Abstract] [Full Text] [Related]

  • 25. Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells.
    Petak I, Tillman DM, Harwood FG, Mihalik R, Houghton JA.
    Cancer Res; 2000 May 15; 60(10):2643-50. PubMed ID: 10825136
    [Abstract] [Full Text] [Related]

  • 26. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
    Chen MJ, Chiou PP, Lin P, Lin CM, Siri S, Peck K, Chen TT.
    J Cell Biochem; 2007 Aug 01; 101(5):1316-27. PubMed ID: 17286280
    [Abstract] [Full Text] [Related]

  • 27. "Thymineless" death in androgen-independent prostatic cancer cells.
    Kyprianou N, Isaacs JT.
    Biochem Biophys Res Commun; 1989 Nov 30; 165(1):73-81. PubMed ID: 2531584
    [Abstract] [Full Text] [Related]

  • 28. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T, Suzuki N, Yamaguchi M, Ohshimo H, Fukushima M.
    Int J Oncol; 2004 Sep 30; 25(3):571-8. PubMed ID: 15289858
    [Abstract] [Full Text] [Related]

  • 29. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
    Kaufmann SH.
    Cancer Res; 1989 Nov 01; 49(21):5870-8. PubMed ID: 2790800
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC, Jiang XP, Elliott RL, Head JF.
    Anticancer Res; 2001 Nov 01; 21(3B):1777-87. PubMed ID: 11497259
    [Abstract] [Full Text] [Related]

  • 31. Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin).
    Sensibar JA, Sutkowski DM, Raffo A, Buttyan R, Griswold MD, Sylvester SR, Kozlowski JM, Lee C.
    Cancer Res; 1995 Jun 01; 55(11):2431-7. PubMed ID: 7757997
    [Abstract] [Full Text] [Related]

  • 32. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618
    [Abstract] [Full Text] [Related]

  • 33. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K, Su J, Trovitch PB.
    J Pharm Pharmacol; 2003 Aug 15; 55(8):1135-41. PubMed ID: 12956904
    [Abstract] [Full Text] [Related]

  • 34. Induction of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death.
    Kyprianou N, Bains AK, Jacobs SC.
    Prostate; 1994 Aug 15; 25(2):66-75. PubMed ID: 8036180
    [Abstract] [Full Text] [Related]

  • 35. Mechanism and role of growth arrest in programmed (apoptotic) death of prostatic cancer cells induced by thapsigargin.
    Lin XS, Denmeade SR, Cisek L, Isaacs JT.
    Prostate; 1997 Nov 01; 33(3):201-7. PubMed ID: 9365549
    [Abstract] [Full Text] [Related]

  • 36. Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C.
    Bougen NM, Yang T, Chen H, Lobie PE, Perry JK.
    Oncol Rep; 2011 Aug 01; 26(2):487-93. PubMed ID: 21567106
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells.
    McCloskey DE, Kaufmann SH, Prestigiacomo LJ, Davidson NE.
    Clin Cancer Res; 1996 May 01; 2(5):847-54. PubMed ID: 9816240
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.